The stock pared almost all its gains and finally ended at Rs 30. Around 957,878 shares were traded as compared to the two-week daily average traded volumes of 120,571 shares on the BSE.
__________________________________________
(Updated at 1054hrs)
Suven Life Sciences has soared 3% following the news that company secured two Canadian patents on new chemical entities for treating disorders associated with neuro degenarative diseases during the trading hours on Monday.
The scrip opened at Rs 32 and is now firm at Rs 31, up 3% from the previous close. The counter has clocked volumes of 676,468 shares as compared to the two-week daily average traded volumes of 120,571 shares on the BSE.
The scrip has advanced 15% in a month's time.